PNPLA3 and metabolic dysfunction-associated steatotic liver disease: In summary, these findings have demonstrated the novel idea that PNPLA3 rs738409 may robustly affect the pathogenesis of NAFLD in non-obese individuals compared with obese individuals and may have an additive joint effect along with changes in lifestyle such as weight gain ≥10 kg after age 20.